Performance of the screening program

BreastScreen Australia has been monitored since 1996–1997 using national performance indicators, which are key measures of the progress BreastScreen Australia is making towards reducing morbidity and mortality from breast cancer.

The Population Based Screening Framework (Standing Committee on Screening 2018) uses 5 incremental stages to describe a population screening pathway (recruitment, screening, assessment, diagnosis and outcomes). The performance indicator data in this monitoring report have been applied to these stages, and this figure shows how the indicators relate to the framework for data presented in this report.

Figure Performance 1: Summary of BreastScreen Australia performance indicators for this report

This diagram illustrates the summary of BreastScreen Australia performance indicators.

PI = performance indicator.

Notes

  1. Participation PI 1 is reported for the 2-year calendar period 2022–2023. Rescreening PI 2 is reported for the index year 2021. Recall to assessment PI 3, invasive breast cancer detection PI 4 and DCIS detection PI 5 are reported for 2023. Interval cancer PI 6a and program sensitivity PI 6b are reported for the index years 2018, 2019 and 2020. Breast cancer incidence PI 7a and DCIS incidence PI 7b are reported for 2021. Mortality PI 8 is reported for 2023.
  2. All rates are crude rates.

Sources: AIHW analysis of BreastScreen Australia data; AIHW Australian Cancer Database 2021; AIHW National Mortality Database.

 

Previous page
Next page